
    
      Prior to transplantation, subjects will receive Melphalan, Fludarabine and Anti-Thymocyte
      Globulin (ATG) or Campath. These three drugs are being given to subjects to help the new stem
      cells take and grow. On the day of transplantation, subjects will receive stem cells
      transfused via intravenous (IV) catheter.

      After stem cell transplantation, subjects will be given Cyclosporin A (CsA) and mycophenolate
      mofetil (MMF) to reduce the risk of graft-versus-host disease, the complication that occurs
      when the donor's stem cells react against the patient.
    
  